<DOC>
	<DOCNO>NCT01376154</DOCNO>
	<brief_summary>The purpose study confirm efficacy safety administer lamivudine tablet alone subject hepatitis B virus-induced liver cirrhosis .</brief_summary>
	<brief_title>Special Drug Use Investigation ZEFIX ( Lamivudine ) Tablet ( HBV Cirrhosis )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Subjects hepatitis B virusinduced liver cirrhosis , lamivudine tablet administer alone 6 month longer , lamivudine tablet expect administer alone 6 month long Subjects previously enrol Drug Use Investigation Special Drug Use Investigation lamivudine tablet Subjects history hypersensitivity ingredient lamivudine tablet</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>